These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 9667790)
1. Total elimination of measles in Finland. Heinonen OP; Paunio M; Peltola H Ann Med; 1998 Apr; 30(2):131-3. PubMed ID: 9667790 [TBL] [Abstract][Full Text] [Related]
2. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program. Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278 [TBL] [Abstract][Full Text] [Related]
3. Administration of measles-mumps-rubella vaccination with other childhood schedule vaccines. Heath TC; Burgess MA; O'Brien ED Commun Dis Intell; 1998 Aug; 22(8):159. PubMed ID: 9735551 [No Abstract] [Full Text] [Related]
4. Rapid effect on endemic measles, mumps, and rubella of nationwide vaccination programme in Finland. Peltola H; Karanko V; Kurki T; Hukkanen V; Virtanen M; Penttinen K; Nissinen M; Heinonen OP Lancet; 1986 Jan; 1(8473):137-9. PubMed ID: 2867355 [TBL] [Abstract][Full Text] [Related]
6. Antibodies to measles, mumps and rubella in UK children 4 years after vaccination with different MMR vaccines. Miller E; Hill A; Morgan-Capner P; Forsey T; Rush M Vaccine; 1995 Jun; 13(9):799-802. PubMed ID: 7483800 [TBL] [Abstract][Full Text] [Related]
7. [Vaccination rate for triple measles-rubella-mumps vaccine in Empoli Val d'Elsa area health district U.S.L. 11, Tuscany Region]. Salvadori P Ann Ig; 1998; 10(1):19-24. PubMed ID: 9616974 [No Abstract] [Full Text] [Related]
8. Clinical evaluation of a new measles-mumps-rubella combined live virus vaccine in the Dominican Republic. Ehrenkranz NJ; Ventura AK; Medler EM; Jackson JE; Kenny MT Bull World Health Organ; 1975; 52(1):81-5. PubMed ID: 764997 [TBL] [Abstract][Full Text] [Related]
9. From the Centers for Disease Control and Prevention. Measles--United States, 1996, and the interruption of indigenous transmission. JAMA; 1997 May; 277(17):1345-6. PubMed ID: 9134928 [No Abstract] [Full Text] [Related]
10. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996]. Zäch K; Nicoara C; Germann D; Matter L Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837 [TBL] [Abstract][Full Text] [Related]
11. A field with a liver measles-mumps-rubella vaccine. Walters VW; Miller SA; Jackson JE; Kenny MT Clin Pediatr (Phila); 1975 Oct; 14(10):928-33. PubMed ID: 1100294 [TBL] [Abstract][Full Text] [Related]
12. MMR vaccine coverage at 24 months stabilises in the UK. Commun Dis Rep CDR Wkly; 1999 Mar; 9(13):113, 116. PubMed ID: 10230112 [No Abstract] [Full Text] [Related]
13. Catch-up immunization programs will eliminate measles threat for most schoolchildren. Rafuse J CMAJ; 1996 May; 154(10):1567-8. PubMed ID: 8625011 [TBL] [Abstract][Full Text] [Related]
14. The measles-mumps-rubella vaccination program in Finland. Redd SC; Wharton M; Hadler SC; Orenstein WA N Engl J Med; 1995 Apr; 332(16):1102-3. PubMed ID: 7898540 [No Abstract] [Full Text] [Related]
15. Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs. eleven to thirteen years. Johnson CE; Kumar ML; Whitwell JK; Staehle BO; Rome LP; Dinakar C; Hurni W; Nalin DR Pediatr Infect Dis J; 1996 Aug; 15(8):687-92. PubMed ID: 8858673 [TBL] [Abstract][Full Text] [Related]
16. Need for measles revaccination. John TJ Indian Pediatr; 1998 Aug; 35(8):789-91. PubMed ID: 10216577 [No Abstract] [Full Text] [Related]
17. Evaluation of live trivalent vaccine of measles AIK-C strain, mumps Hoshino strain and rubella Takahashi strain, by virus-specific interferon-gamma production and antibody response. Nakayama T; Urano T; Osano M; Nakagawa M; Maehara N; Sasaki K; Yamamura AM; Makino S Microbiol Immunol; 1990; 34(6):497-508. PubMed ID: 2120551 [TBL] [Abstract][Full Text] [Related]
18. [Certain problems with limits of immunity against measles, mumps and rubella]. Magdzik W Przegl Epidemiol; 1993; 47(1-2):47-53. PubMed ID: 8351387 [TBL] [Abstract][Full Text] [Related]
19. A second dose of MMR vaccine for children in the United Kingdom. Commun Dis Rep CDR Wkly; 1996 Jul; 6(30):259. PubMed ID: 8755703 [No Abstract] [Full Text] [Related]
20. Increased protections during a measles outbreak of children previously vaccinated with a second dose of measles-mumps-rubella vaccine. Vitek CR; Aduddell M; Brinton MJ; Hoffman RE; Redd SC Pediatr Infect Dis J; 1999 Jul; 18(7):620-3. PubMed ID: 10440438 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]